Daré Bioscience Statistics
Total Valuation
DARE has a market cap or net worth of $28.43 million. The enterprise value is $18.20 million.
Market Cap | 28.43M |
Enterprise Value | 18.20M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DARE has 100.58 million shares outstanding. The number of shares has increased by 3.23% in one year.
Shares Outstanding | 100.58M |
Shares Change (YoY) | +3.23% |
Shares Change (QoQ) | -3.85% |
Owned by Insiders (%) | 1.65% |
Owned by Institutions (%) | 6.61% |
Float | 98.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.13 |
Forward PS | 6.66 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 6.48 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86
Current Ratio | 0.86 |
Quick Ratio | 0.61 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -120.80% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $122,082 |
Profits Per Employee | -$1.31M |
Employee Count | 23 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.28% in the last 52 weeks. The beta is 1.21, so DARE's price volatility has been higher than the market average.
Beta (1Y) | 1.21 |
52-Week Price Change | -72.28% |
50-Day Moving Average | 0.46 |
200-Day Moving Average | 0.49 |
Relative Strength Index (RSI) | 27.05 |
Average Volume (30 Days) | 360,780 |
Short Selling Information
The latest short interest is 235,035, so 0.23% of the outstanding shares have been sold short.
Short Interest | 235,035 |
Short Previous Month | 456,200 |
Short % of Shares Out | 0.23% |
Short % of Float | 0.24% |
Short Ratio (days to cover) | 0.68 |
Income Statement
In the last 12 months, DARE had revenue of $2.81 million and -$30.16 million in losses. Loss per share was -$0.35.
Revenue | 2.81M |
Gross Profit | 2.81M |
Operating Income | -30.94M |
Pretax Income | -30.16M |
Net Income | -30.16M |
EBITDA | -30.07M |
EBIT | -30.16M |
Loss Per Share | -$0.35 |
Balance Sheet
The company has $11.64 million in cash and $1.40 million in debt, giving a net cash position of $10.24 million or $0.10 per share.
Cash & Cash Equivalents | 11.64M |
Total Debt | 1.40M |
Net Cash | 10.24M |
Net Cash Per Share | $0.10 |
Equity / Book Value | -5.05M |
Book Value Per Share | -0.05 |
Working Capital | -2.94M |
Cash Flow
In the last 12 months, operating cash flow was -$38.86 million and capital expenditures -$629,430, giving a free cash flow of -$39.49 million.
Operating Cash Flow | -38.86M |
Capital Expenditures | -629,430 |
Free Cash Flow | -39.49M |
FCF Per Share | -$0.45 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,101.89% and -1,074.17%.
Gross Margin | 100.00% |
Operating Margin | -1,101.89% |
Pretax Margin | -1,074.17% |
Profit Margin | -1,074.17% |
EBITDA Margin | -1,070.88% |
EBIT Margin | -1,074.17% |
FCF Margin | -1,406.26% |
Dividends & Yields
DARE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.23% |
Shareholder Yield | -3.23% |
Earnings Yield | -106.07% |
FCF Yield | -138.87% |
Analyst Forecast
The average price target for DARE is $6.00, which is 2,022.39% higher than the current price. The consensus rating is "Buy".
Price Target | $6.00 |
Price Target Difference | 2,022.39% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 154.66% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 20, 2017. It was a reverse split with a ratio of 1:10.
Last Split Date | Jul 20, 2017 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
DARE has an Altman Z-Score of -15.33. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -15.33 |
Piotroski F-Score | n/a |